Matches in Wikidata for { <http://www.wikidata.org/entity/Q91574814> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q91574814 description "artículu científicu espublizáu n'abril de 2020" @default.
- Q91574814 description "scientific article published on 05 April 2020" @default.
- Q91574814 description "wetenschappelijk artikel" @default.
- Q91574814 description "наукова стаття, опублікована 5 квітня 2020" @default.
- Q91574814 name "Acquired resistance to trastuzumab/pertuzumab or to T-DM1 in vivo can be overcome by HER2 kinase inhibition with TAS0728" @default.
- Q91574814 name "Acquired resistance to trastuzumab/pertuzumab or to T-DM1 in vivo can be overcome by HER2 kinase inhibition with TAS0728" @default.
- Q91574814 type Item @default.
- Q91574814 label "Acquired resistance to trastuzumab/pertuzumab or to T-DM1 in vivo can be overcome by HER2 kinase inhibition with TAS0728" @default.
- Q91574814 label "Acquired resistance to trastuzumab/pertuzumab or to T-DM1 in vivo can be overcome by HER2 kinase inhibition with TAS0728" @default.
- Q91574814 prefLabel "Acquired resistance to trastuzumab/pertuzumab or to T-DM1 in vivo can be overcome by HER2 kinase inhibition with TAS0728" @default.
- Q91574814 prefLabel "Acquired resistance to trastuzumab/pertuzumab or to T-DM1 in vivo can be overcome by HER2 kinase inhibition with TAS0728" @default.
- Q91574814 P1433 Q91574814-60C0A79D-EB8E-4F08-86E5-9FE0A954F28E @default.
- Q91574814 P1476 Q91574814-9DEFA24E-9A33-4D75-8AAC-992E9CB06D02 @default.
- Q91574814 P2093 Q91574814-3B214E0C-6355-417A-A00B-900D43EB3730 @default.
- Q91574814 P2093 Q91574814-3B524507-ABE3-48CB-AC7E-ABDB48D6B62E @default.
- Q91574814 P2093 Q91574814-58647795-D011-4A79-8E19-31405E886460 @default.
- Q91574814 P2093 Q91574814-9D1B46AF-F85C-4CCD-8E61-6650916CF164 @default.
- Q91574814 P2093 Q91574814-B2C814DB-56A8-44DB-A881-31EDAC4287F5 @default.
- Q91574814 P2093 Q91574814-C6F4D866-384D-414A-A4D1-03B150AA8CDB @default.
- Q91574814 P2093 Q91574814-E1B52DEC-E1C7-47AD-A7F5-D61F5FFFEA43 @default.
- Q91574814 P2093 Q91574814-F6576BD7-35C5-40C3-86A8-E759DC7E672B @default.
- Q91574814 P2860 Q91574814-45C086EE-E4AD-4AAB-8C2C-B40BB361D8E7 @default.
- Q91574814 P31 Q91574814-22AEC473-68CE-49BF-A45C-DCA1E9BF994B @default.
- Q91574814 P356 Q91574814-91F73D57-8B87-4720-9E64-0C51A3758236 @default.
- Q91574814 P50 Q91574814-53334488-4760-44CE-A65B-AA2DEA22E03B @default.
- Q91574814 P50 Q91574814-BB0AF6E4-4694-4594-8A59-F0DACEE90B8A @default.
- Q91574814 P577 Q91574814-F52F2CCD-4C6A-4AC1-A706-020EEF1A63BC @default.
- Q91574814 P698 Q91574814-E1FC0CA8-129F-4541-BC85-556BB6E47575 @default.
- Q91574814 P932 Q91574814-3FFDC084-503F-4066-9F0A-1922DF2D04E9 @default.
- Q91574814 P356 CAS.14407 @default.
- Q91574814 P698 32248641 @default.
- Q91574814 P1433 Q326125 @default.
- Q91574814 P1476 "Acquired resistance to trastuzumab/pertuzumab or to T-DM1 in vivo can be overcome by HER2 kinase inhibition with TAS0728" @default.
- Q91574814 P2093 "Fumio Nakagawa" @default.
- Q91574814 P2093 "Hideki Nagase" @default.
- Q91574814 P2093 "Hiraku Itadani" @default.
- Q91574814 P2093 "Junji Uchida" @default.
- Q91574814 P2093 "Kenichi Matsuo" @default.
- Q91574814 P2093 "Kimihiro Ito" @default.
- Q91574814 P2093 "Rumi Kawabata" @default.
- Q91574814 P2093 "Yayoi Fujioka" @default.
- Q91574814 P2860 Q34880994 @default.
- Q91574814 P31 Q13442814 @default.
- Q91574814 P356 "10.1111/CAS.14407" @default.
- Q91574814 P50 Q72932243 @default.
- Q91574814 P50 Q91574808 @default.
- Q91574814 P577 "2020-04-05T00:00:00Z" @default.
- Q91574814 P698 "32248641" @default.
- Q91574814 P932 "7293079" @default.